← Back to all articles
Clinical TrialsPubMed VerifiedOpen Access

Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study

Perkins D, Halman A, Urokohara A, Sarris J

Scientific Reports (2025)

Phase 1 trial
Abstract

Phase 1 trial across 17 dosing sessions in 9 healthy volunteers found strong dose-dependent correlations between a purified DMT-harmala capsule formulation and mystical experience intensity, with acute experiences predicting sustained beneficial psychological outcomes.

Participants9
Study TypePhase 1 trial
phase 1DMT-harmalacapsuledose-dependentmystical experience
DOI: 10.1038/s41598-025-25767-xView on PubMed

Related Articles

Clinical Trials

Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind

Melani A, Papini G et al.

Biomedicines, 2026
Clinical Trials

Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-dimethyltryptamine and harmine

Dornbierer DA, Marten L et al.

Frontiers in Pharmacology, 2023
Clinical Trials

Effects of ayahuasca on mental health and quality of life in naive users: A longitudinal and cross-sectional study combination

Jimenez-Garrido DF, Gomez-Sousa M et al.

Scientific Reports, 2020
Reviews

The effects of ayahuasca on psychological disorders: a systematic literature review

Sheth R, Parikh E et al.

Cureus, 2024